Common antidepressant does not aid stroke recovery, study finds

stroke
Credit: CC0 Public Domain

Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.

Earlier research from France had suggested that taking the drug, called fluoxetine, might reduce disability after .

The latest study found no difference between the improvement in physical ability of stroke patients who took fluoxetine for six months and those who took a placebo—an inactive substitute.

Experts stress that people already taking the drug should not stop without speaking to their doctor first.

Fluoxetine is a common type of antidepressant that includes the branded drugs Prozac and Prozep.

The University of Edinburgh-led study involved more than 3000 at over 100 hospitals around the UK.

Half of the participants started taking fluoxetine daily within the first two weeks of their stroke, while the remainder took a placebo.

Those who took fluoxetine were less likely to develop depression, but, there was a small increase in reported in this group.

Researchers say their findings do not support the use of fluoxetine to promote recovery after stroke in the UK.

The study, called FOCUS, is published in The Lancet and was funded by the Stroke Association and the National Institute for Health Research (NIHR). The findings are being announced at the UK Stroke Forum annual conference in Telford, UK.

Co-chief investigator Professor Gillian Mead, of the University of Edinburgh's Centre for Clinical Brain Sciences, said: "FOCUS has shown that there is no benefit in the routine prescription of fluoxetine to improve recovery after a stroke, contrary to the promising results of smaller trials.

"There are other reasons a patient may be prescribed and we do not recommend that people change their treatment regimen without first consulting with their doctor."


Explore further

Research in mice shows potential value of antidepressant in some stroke victims

More information: Martin Dennis et al, Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial, The Lancet (2018). DOI: 10.1016/S0140-6736(18)32823-X
Journal information: The Lancet

Citation: Common antidepressant does not aid stroke recovery, study finds (2018, December 5) retrieved 15 July 2019 from https://medicalxpress.com/news/2018-12-common-antidepressant-aid-recovery.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more